Skip to main content

Closed

INVA: Innoviva, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+15.5% / yr

Operating margin14.8%

ROIC2.9%

Financially safe

Adequate

Debt / equity0.25×

Interest coverage3.6×

Current ratio21.13×

Valuation

Unrated

P/E ratio3.0×

Innoviva, Inc.

INVANASDAQ Global Select·USD·Closed

Innoviva, Inc.

INVANASDAQ·USD·Closed

$20.97

−1.18%

$20.97

−$0.25 (1.18%)

52W Range

52thpctl

Volume

0.58×avg

Mkt Cap

1.55BUSD

P/E

3.0TTM

Div Yield

–ann

52W Range

52thpctl

Volume

0.58×avg

Market Cap

1.55BUSD

P/E Ratio

3.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings